Synta Pharma (SNTA) Misses Q3 Views; Loss Wider by 3c
Tweet Send to a Friend
Synta Pharmaceuticals Corp. (Nasdaq: SNTA) reports Q3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
